Benign prostatic hyperplasia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Western medicine by clinical diagnosis confirmed benign prostatic hyperplasia; 2. TCM dialectical classification for Qi deficiency and blood stasis, damp-heat syndrome; 3. Male subjects aged between 40 and 85 (including 40 and 85 years); 4. Nearly three months, transabdominal prostate B ultrasound measurement, prostate weight greater than 20g (calculation formula: prostate weight m = 0.546 × prostate triangular product); 5. Subjects voluntarily attend and sign informed consent.
Exclusion criteria
Exclusion criteria: 1. allergies and allergy to the drug; 2. combined with severe neurological diseases, lumbar disc herniation, spinal stenosis, lower abdomen and pelvic surgery, severe diabetes and other causes of neurogenic bladder disease; 3. combined with bladder new creatures, ureteral ridge, fine Fu hypertrophy, bladder neck sclerosis; Blood PSA> 4ng / ml; (ALT> 1.5 × ULN, AST> 1.5 × ULN), renal function (Cr> 1.5 × ULN) or combined with cardiovascular and cerebrovascular, liver, kidney, hematopoietic system and other serious primary diseases, Serious diseases that affect their survival, such as cancer or AIDS; 6. severe gastritis, stomach and duodenal ulcer; 7. severe renal dysfunction, urinary retention in patients; 8. According to the researchers' judgment, there are other diseases that reduce the possibility of grouping or complicate the group, such as frequent changes in the working environment and so on. 9. Other circumstances that the investigator considers unsuitable for inclusion.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| I-PSS; | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of life score;Maximum urinary flow rate;Prostate volume; | — |
Countries
China
Contacts
Zhejiang University of Traditional Chinese Medicine Affiliated First Hospital